US calls for pause on Johnson & Johnson's Covid-19 vaccine
Published: Apr 13, 2021 12:00 PM
US federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's single-dose COVID-19 vaccine after six recipients developed a rare disorder involving blood clots.
The U.S. Centers for Disease Control and Prevention will hold an advisory meeting on Wednesday to review the cases.
View Comments0
Report this comment
500 characters remaining


Are you sure you want to delete this comment?
This action cannot be undone.